For years, key opinion leaders (KOLs) have held a position of authority and respect amongst…
Stephen Riddle

Stephen Riddle
Stephen is a top-notch and professional content writer at TopPharmaNews.com. He primarily focuses on news related to the Pharma News Field, particularly the groundbreaking discoveries taking place in the sector. It includes various clinical researches, findings, along with some happenings in the Pharma field. Additionally, he is an editorial assistant at the site. Thus, he keeps track of the news being published on TopPharmaNews.com.
The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a…
Servier is on course to get a return on its $1.8 billion takeover of Agios…
Eli Lilly’s home state of Indiana is set to benefit from a massive $2.1 billion…
Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a…
Cumulus Neuroscience has started a pair of clinical trials to gauge the value of a…
In the diverse world we live in, the products we produce, the services we create…
After more than six years of development, Angle has scored an FDA approval for Parsortix…
Shares in US biotech Verrica Pharma lost half their value today after the FDA declined…
Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of…
Around 100 patients in England and Wales with triple negative breast cancer (TNBC) that has…
This post was originally published on Source Link
Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA…
US pharma giant Pfizer has said it will sell some of its patented medicines at…
Most pharma and biopharma executives agree the patient voice should be at the centre of…
Value is a tricky concept to capture accurately. Given the diverse and complex world that…
As healthcare evolves to become more consumer-centric, the value of social health – the dynamic,…
Shares in US biotech Nymox Pharma have plunged after the company announced the FDA had…
Eli Lilly has the results it was looking for in a second, confirmatory trial of…
AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar…
Industrial action at several GlaxoSmithKline manufacturing plants in the UK has been called off, after…
The pharma industry is becoming an increasingly hot commodity for cybercriminals. In recent years, digital…
Data is the powerhouse of the pharmaceutical sector. It powers drug discovery, clinical trials, and…
The World Health Organization has said the current outbreak of monkeypox is the largest ever…
A study that will look at the feasibility of tracking people’s lifestyle habits for an…
This article follows part one of our two-part series, in which we discussed how USAID…
Telehealth company Amwell has marked Mental Health Awareness month with the launch of a digital…
Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent…
AbbVie has filed for approval of its therapy for Parkinson’s disease, ABBV-951, which promises continuous…
Sanofi’s Genzyme unit has moved a step closer to securing EU approval for Xenpozyme –…
PTC Therapeutic’s Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended…
The primary care setting has garnered significant attention from industry stakeholders due to its promise…
- Pharma News
On Clinical Trials Day, CVS shares lessons learned from one year providing trial services
CVS Health has come a long way from its humble beginnings as a health and…
In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for…
A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in…
Several of the top pharmaceutical companies have joined a new coalition that aims to improve…
UK scientists are being denied from joining the €95 billion Horizon research funding programme as…
After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft…
In collaboration with leading integrin drug developers, including Genentech, 7 Hills Pharma, and Pfizer, the 2nd Integrin-Targeted Drug Development…
- Pharma News
How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast
In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with…
Joined up data could transform the pharmaceutical industry and help create a healthier Europe for…
The inaugural Targeted Radiopharmaceuticals Summit US will bring together a worldwide community of specialists to address long-standing…
An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate…
Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies…
Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of…
Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving…
Merck & Co has quietly added another drug to its immuno-oncology pipeline via an agreement…
The benefits of conducting a regular KOL validation exercise to refresh your KOL list are…
SwanBio Therapeutics has raised $56 million in a second-round financing that will be used to…
Companies trying to bring digital therapeutic (DTx) products through development and onto the market have…